FDA Inspection 816465 — Beijing Taiyang Pharmaceutical Industry Company Ltd
The FDA completed an inspection of Beijing Taiyang Pharmaceutical Industry Company Ltd on January 16, 2013 in Beijing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 16, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Beijing (China)